Albany, NY -- (SBWIRE) -- 10/07/2014 -- The pharmaceutical industry is witnessing a shift in focus from molecular drugs to protein based drugs due to its high specificity, enhanced efficacy, affinity, solubility, and low incidences of toxicity. The market for protein drugs is segmented into antibody drugs, peptide hormones, blood products and enzymes market. The antibody segment is one of the fastest growing areas in this market. Some of the commercially available antibody drugs are Adcetris (brentuximab vedotin) marketed by Seattle Genetics and Millennium/Takeda and Kadcyla (trastuzumab emtansine) marketed by Genentech and Roche. Insulin was the first peptide isolated and used as a therapeutic agent. Today there is a long list of peptides used therapeutically such as octreotide used in cancer treatment, amylin, pramlintide and glucagon-like peptide-1 (GLP-1). Rituxan (rituximab), Erbitux (cetuximab) are leading brand names in the monoclonal antibodies segment.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/protein-drugs-market.html

Continued development in the arena of proteomics and nanotechnology, improved protein based drug efficacy and safety, advances in drug delivery system and rapid increase in chronic diseases are some of the major factors supporting the growth of this market. Geographically, North America represents the largest market, as majority of the key players are domiciled in United States and thus many new drugs first are introduced in these regions. Other factors contributing growth in these regions are a large population base affected with chronic and autoimmune diseases and reimbursement policy covering almost major chronic diseases such as diabetes, cardiovascular and autoimmune diseases. North America is followed by Europe and Asia-Pacific. Emerging countries in Asia-Pacific and Latin America including India, China, Brazil and Mexico are predicted to experience a substantial growth due to improved economic scenario and continued improvement in healthcare facilities.

Some of the prominent players operating in this market space are Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech Inc., Johnson & Johnson, Bristol-Myers Squibb, Novo Nordisk, Biogen Idec, Dendreon Corporation and Amgen Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2034

Latest Upcoming Reports: http://www.transparencymarketresearch.com/upcoming.htm

Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Browse Market Research Blogs:
http://www.tmrblog.com/
http://pharmaceuticalmarket.wordpress.com/